1Q earnings: Astrana Health reports $0.31 EPS, $404.36M revenue, misses estimates, updates FY24 guidance to $1.28-$1.52 EPS.
Astrana Health reported Q1 earnings with EPS of $0.31, missing estimates by $0.01, and $404.36M revenue, slightly below expectations. FY24 guidance updated to $1.28-$1.52 EPS. The company has a market cap of $2.13B, P/E 28.74, PEG 1.20, and beta 1.12. Truist Financial upgraded price target to $44.00 (hold rating), and Jefferies Financial Group gave a buy rating with a $50.00 target.
May 08, 2024
3 Articles